Balyasny Asset Management LLC Procept Bio Robotics Corp Transaction History

Balyasny Asset Management LLC

  • $63.6 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$24.89 - $43.41 $275,283 - $480,114
11,060 Added 41.37%
37,797 $1.58 Million
Q3 2023

Nov 14, 2023
BUY
$30.02 - $38.81 $802,644 - $1.04 Million
26,737 New
26,737 $877,000
Q4 2021

Feb 14, 2022
SELL
$24.6 - $46.29 $722,133 - $1.36 Million
-29,355 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$35.91 - $41.94 $1.05 Million - $1.23 Million
29,355 New
29,355 $1.12 Million

Others Institutions Holding PRCT

# of Institutions
295
Shares Held
41.6M
Call Options Held
196K
Put Options Held
141K
View Full List

About PROCEPT BioRobotics Corp

PRCT Quotes by TradingView
  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.78B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email